Glycogen: an overview of possible regulatory roles of the proteins associated with the granuleThis paper is one of a selection of papers published in this Special Issue, entitled 14th International Biochemistry of Exercise Conference – Muscles as Molecular and Metabolic Machines, and has undergone the Journal’s usual peer review process.

While scientists have routinely measured muscle glycogen in many metabolic situations for over 4 decades, there is surprisingly little known regarding its regulation. In the past decade, considerable evidence has illustrated that the carbohydrate stores in muscle are not homogeneous, and it is very likely that metabolic pools exist or that each granule has independent regulation. The fundamental aspects appear to be associated with a complex set of proteins that associate with both the granule and each other in a dynamic fashion. Some of the proteins are enzymes and others play scaffolding roles. A number of the proteins can translocate, depending on the metabolic stimulus. These various processes appear to be the mechanisms that give the glycogen granule precise yet dynamic regulation. This may also allow the stores to serve as an important metabolic regulator of other metabolic events.

Glycogenin protein and mRNA expression in response to changing glycogen concentration in exercise and recovery

Glycogenin (GN-1) is essential for the formation of a glycogen granule; however, rarely has it been studied when glycogen concentration changes in exercise and recovery. It is unclear whether GN-1 is degraded or is liberated and exists as apoprotein (apo)-GN-1 (unglycosylated). To examine this, we measured GN-1 protein and mRNA level at rest, at exhaustion (EXH), and during 5 h of recovery in which the rate of glycogen restoration was influenced by carbohydrate (CHO) provision. Ten males cycled (65% V̇o2 max) to volitional EXH (117.8 ± 4.2 min) on two separate occasions. Subjects were administered carbohydrate (CHO; 1 g·kg−1·h−1 Gatorlode) or water [placebo (PL)] during 5 h of recovery. Muscle biopsies were taken at rest, at EXH, and following 30, 60, 120, and 300 min of recovery. At EXH, total glycogen concentration was reduced ( P < 0.05). However, GN-1 protein and mRNA content did not change. By 5 h of recovery, glycogen was resynthesized to ∼60% of rest in the CHO trial and remained unchanged in the PL trial. GN-1 protein and mRNA level did not increase during recovery in either trial. We observed modest amounts of apo-GN-1 at EXH, suggesting complete degradation of some granules. These data suggest that GN-1 is conserved, possibly as very small, or nascent, granules when glycogen concentration is low. This would provide the ability to rapidly restore glycogen during early recovery.

The “Glycogen Granule” Revisited

There is a gap between biochemical findings and ultrastructural interpretation of “glycogen granules”. Biochemists have recognized that glycogen contains covalently bound proteins. These include enzymes involved in giycogen metabolism: glycogenin (protein primer responsible for initiation of glycogen synthesis), glycogen synthase and phosphorylase, and presumably other regulatory enzymes. The structures formed by the association of glycogen and protein have been called protein-glycogen complexes, considered as proteoglycans, or as dynamic cellular organelles, glycosomes.The question arises as to why the biochemical recognition of a protein component in glycosomes has not been acknowledged in electron microscopy (EM)? This protein is visible in every section stained by uranium (U) and lead (Pb) salts where it appears as 20-30 nm granules (Fig. 1). However, these granules are commonly interpreted as glycogen, despite the fact that glycogen does not react with ionic compounds and therefore cannot be stained by U-Pb.